Lynk Pharmaceuticals
formerly Lynk Pharma (凌科药业)Making a Difference to Patients’ Lives with Innovation
Hangzhou, China · $147.6M raised
- Headquarters
- Hangzhou
- Business Model
- B2B
- Website
- lynkpharma.com
- Total Funding
- $147.6M
- Last Round
- $47.9M Series CSep 2023
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Lynk Pharmaceuticals is a clinical-stage drug developer focused on autoimmune and inflammatory diseases and on differentiated small-molecule treatments that can provide oral alternatives to biologics. Its research centers on JAK-STAT and TYK2 signaling pathways and targeted protein degradation. The company integrates AI-assisted drug design, biological evaluation, and protein-degradation technologies across target discovery, molecular design, translational research, and clinical development.
Summary
Lynk Pharmaceuticals is a Biotech company based in Hangzhou, China. It has raised $147.6M in total across 4 rounds, most recently a $47.9M Series C round in Sep 2023. Investors include Lilly Asia Ventures, Legend Capital and New Alliance Capital.
Funding History
Sep 2023
Sign up to see all 4 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lynk-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/lynk-pharmaceuticals" alt="Lynk Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>